首页> 外文期刊>Journal of gastroenterology and hepatology >High incidence of newly-developed gastroesophageal reflux disease in the Japanese community: a 6-year follow-up study.
【24h】

High incidence of newly-developed gastroesophageal reflux disease in the Japanese community: a 6-year follow-up study.

机译:日本社区新发的胃食管反流病高发:一项为期6年的随访研究。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND AND AIM: We conducted a community-based study to assess the incidence of newly-developed gastroesophageal reflux disease (GERD). We also analyzed the risk factors of GERD occurrence. METHODS: A total of 322 patients without acid suppression therapy (135 men, mean age: 59.8 years), who lived in the Japanese community, took a QUEST questionnaire (a self-administered questionnaire for the screening of GERD) in 1998. Blood samples were taken for the measurement of an anti-Helicobacter pylori antibody and pepsinogen (PG) I/II to assess the grade of gastric atrophy. Of these patients, 289 scored less than six points and were diagnosed as non-GERD. Two-hundred-and-forty-one patients (95 men, mean age: 67.0 years) took the QUEST questionnaire again in 2004 (after 6 years). The incidence of newly-developed GERD was analyzed. These patients were categorized into three groups based on their initial PG I/II (group A: less than three, group B: three to six, and group C: more than six). The risk factors of GERD occurrence were evaluated. RESULTS: Of the 241 non-GERD patients, 37 patients (15.4%) developed GERD after 6 years. The incidence of newly-developed GERD in group C was significantly higher than both groups A and B (group A: 3.8% [three of 79], group B: 11.8% (11/93), group C: 33.3% (26/69), P < 0.01, respectively). The prevalence of H. pylori negativity, constipation, and medication of Ca antagonists in newly-developed GERD were significantly higher than in those who did not develop GERD. [Correction added after online publication on 1 July 2007: the preceding sentence has replaced one that read 'The prevalence of H. pylori negativity, constipation, and medication of Ca antagonists in newly-developed GERD were significantly higher than in those who did develop GERD.'] CONCLUSION: The incidence of newly-developed GERD in the Japanese community was 16.5% for 6 years. The incidence of newly-developed GERD patients who scored a PG I/II over six was significantly higher than those who scored lower. H. pylori negativity, constipation, and medication of Ca antagonists might be risk factors of GERD occurrence.
机译:背景与目的:我们进行了一项基于社区的研究,以评估新开发的胃食管反流病(GERD)的发生率。我们还分析了GERD发生的危险因素。方法:1998年,居住在日本社区的总共322例未经酸抑制疗法的患者(135名男性,平均年龄:59.8岁)于1998年接受QUEST问卷(用于自行筛查GERD的问卷)。分别测定抗幽门螺杆菌抗体和胃蛋白酶原(PG)I / II的含量,以评估胃萎缩的程度。在这些患者中,有289分得分低于6分,并被诊断为非GERD。 2004年(2010年)之后,又有241名患者(95名男性,平均年龄:67.0岁)再次接受QUEST问卷调查。分析了新开发的GERD的发生率。根据最初的PG I / II将这些患者分为三组(A组:少于三名,B组:三到六名,C组:超过六名)。评估发生GERD的危险因素。结果:在241名非GERD患者中,有37名(15.4%)在6年后患上GERD。 C组中新发GERD的发生率显着高于A组和B组(A组:3.8%[79个中的三个],B组:11.8%(11/93),C组:33.3%(26 / 69),P <0.01)。在新开发的GERD中,幽门螺杆菌阴性,便秘和Ca拮抗剂治疗的患病率明显高于未开发GERD的人。 [改正是在2007年7月1日在线发布后添加的:之前的句子已替换为'新开发的GERD中幽门螺杆菌阴性,便秘和Ca拮抗剂的患病率显着高于那些GERD的人。结论:在日本社区,最近6年中新发GERD的发生率为16.5%。 PG I / II得分超过6的新出现的GERD患者的发病率显着高于得分较低的GERD。幽门螺杆菌阴性,便秘和Ca拮抗剂治疗可能是GERD发生的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号